Alexandria Co. For Pharmaceuticals & Chemical Industries (EGX:AXPH)

Market Cap	4.06B +93.9%
Revenue (ttm)	3.02B +29.3%
Net Income	494.04M +61.5%
EPS	98.81 +61.5%
Shares Out	5.00M
PE Ratio	8.21
Forward PE	n/a
Dividend	62.95 (7.76%)
Ex-Dividend Date	Nov 4, 2025

Volume	2,789
Average Volume	1,485
Open	798.85
Previous Close	798.85
Day's Range	794.03 - 827.00
52-Week Range	400.02 - 1,000.96
Beta	-0.07
RSI	59.30
Earnings Date	May 14, 2026

About EGX:AXPH

Alexandria Co. For Pharmaceuticals & Chemical Industries operates as a pharmaceutical company in Egypt. The company manufactures, markets, and distributes branded generics of human and animal health products. It also provides human products, such as tablets, syrups, suppositories, drops, ampoule, and crème; medical appliances; and Veterinary Products. In addition, the company offers antibiotics and anesthetics, ophthalmic, cardiovascular, gastrointestinal, genitourinary, and respiratory drugs. Alexandria Co. For Pharmaceuticals & Chemical Indus...

• Industry: Pharmaceutical Preparations
• Founded: 1962
• Country: Egypt
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: AXPH

Financial Performance

In fiscal year 2025, EGX:AXPH's revenue was 2.75 billion, an increase of 55.56% compared to the previous year's 1.77 billion. Earnings were 391.17 million, an increase of 80.53%.